MP23: Bladder Cancer: Invasive III

Saturday, May 14, 2022

8:45 AM – 10:00 AM

Location: Room 225

Poster Session Moderator(s)

AN

Alan Nieder, MD

Columbia university
Katie Murray, DO

University of Missouri
Richard Matulewicz, II, MD,MS,MSc

Assistant Professor
Memorial Sloan Kettering Cancer Center

Presentations:

8:45 AM – 10:00 AM

MP23-01: Urethrectomy at the time of radical cystectomy for non-metastatic urothelial carcinoma of the bladder: a collaborative multicenter study
Poster Presenter: Ekaterina Laukhtina
8:45 AM – 10:00 AM

MP23-02: Early Oncologic outcomes of Open vs Robot-Assisted Radical Cystectomy with totally intracorporeal Urinary Diversion: single centre prospective randomised controlled trial
Poster Presenter: Riccardo Mastroianni, MD
8:45 AM – 10:00 AM

MP23-03: Initial experience using indocyanine green in robotic-assisted ureteroenteric anastomosis
Poster Presenter: Monica Roser Peradejordi Font, MD – Hospital Clinic De Barcelona
8:45 AM – 10:00 AM

MP23-04: Benefit of Neoadjuvant Chemotherapy for Invasive Bladder Cancer Patients Treated with Radiation-based Therapy: An Inverse Probability Treatment Weighted Analysis
Poster Presenter: Ronald Kool, MD
8:45 AM – 10:00 AM

MP23-05: Effect of neoadjuvant chemotherapy in improving overall survival of T2-4aN0M0 bladder cancer patients: A systemic review and meta-analysis according to EAU COVID-19 recommendation
Poster Presenter: Dong Hyuk Kang
8:45 AM – 10:00 AM

MP23-06: Neoadjuvant Chemotherapy before Radical Cystectomy for Muscle-Invasive Bladder Cancer: Patient, Provider, and Clinical Etiologies for Lack of Utilization
Poster Presenter: Ushasi Naha, MD
8:45 AM – 10:00 AM

MP23-07: Prevalence and Impact of Fear of Recurrence on Bladder Cancer Patients after Radical Cystectomy
Poster Presenter: Justin J. Badal, MD
8:45 AM – 10:00 AM

MP23-08: Adverse pathological outcomes of patients with de novo muscle invasive bladder cancer in Northern Ontario
Poster Presenter: Ahmed Kotb, MD,PhD,FEBU,FRCS
8:45 AM – 10:00 AM

MP23-09: Acute kidney injury and its duration in patients treated with radical cystectomy in the Enhanced Recovery After Surgery Era: Optimizing the selection of patients for restrictive fluid therapy
Poster Presenter: Riccardo Leni, MD – IRCCS Ospedale San Raffaele
8:45 AM – 10:00 AM

MP23-10: Longitudinal assessment of 1-yr Health Related Quality of Life outcomes: head to head comparison between Open and Robot-Assisted Radical Cystectomy with totally intracorporeal Urinary Diversion from a single center randomised controlled trial
Poster Presenter: Riccardo Mastroianni, MD
8:45 AM – 10:00 AM

MP23-11: Perioperative Complications after Radical Cystectomy for Bladder Cancer: an International Multicenter Collaboration
Poster Presenter: Chiara Lonati, MD
8:45 AM – 10:00 AM

MP23-12: Emotional Function and early Body Image acceptance as independent predictors of improved long-term Health-Related Quality of Life in patients receiving Radical Cystectomy with Urinary Diversion: implications for perioperative counselling
Poster Presenter: Riccardo Mastroianni, MD
8:45 AM – 10:00 AM

MP23-13: Assessment of baseline functional status and recovery following robot-assisted radical cystectomy with intracorporeal urinary diversion
Poster Presenter: Rand N. Wilcox Vanden Berg, MD
8:45 AM – 10:00 AM

MP23-14: Reducing Readmissions Following Radical Cystectomy Through Quality Improvement
Poster Presenter: Lee W. White, MD, PHD
8:45 AM – 10:00 AM

MP23-15: Impact of previous treatments for prostate cancer on perioperative and oncological outcomes in patients treated with radical cystectomy for bladder cancer
Poster Presenter: Stefano Tappero, MD – IRCCS Policlinico San Martino
8:45 AM – 10:00 AM

MP23-16: Circulating tumor DNA is a strong predictor in patients treated with systemic therapy for urothelial carcinoma
Poster Presenter: Ekaterina Laukhtina
8:45 AM – 10:00 AM

MP23-17: Prognostic and predictive value of preoperative vascular cell adhesion molecule-1 plasma levels in urothelial carcinoma of the bladder treated with radical cystectomy
Poster Presenter: Keiichiro Mori, MD, PhD
8:45 AM – 10:00 AM

MP23-18: Preliminary results of a urine-based DNA methylation test to monitor response to neoadjuvant therapy in muscle-invasive bladder cancer
Poster Presenter: Seyedeh Sanam Ladi Seyedian, MD
8:45 AM – 10:00 AM

MP23-19: Prospective validation of the ROL system in substaging pT1 high-grade bladder cancer: a confirmatory progression risk analysis to ease decision making
Poster Presenter: Piergiuseppe Colombo, MD – Humanitas Clinical and Research Center